Rajendra Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 34 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 89.32%
- Profit Growth 131.85%
- Ebitda 45.78%
- Net Worth 6.03%
- Total Assets 26.35%
About Rajendra Chemicals
Rajendra Chemicals Private Limited (RCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 March 1990 and has a history of 34 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Prem Damani, Rajendrakumar Damani, and Anand Damani serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110MH1990PTC055997
- Company No.
055997
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Rajendra Chemicals Private Limited offer?
Rajendra Chemicals Private Limited offers a wide range of products and services, including Potassium Salts, Potassium Thiocyanate.
Who are the key members and board of directors at Rajendra Chemicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prem Damani  | Director | 27-Sep-1997 | Current |
| Rajendrakumar Damani | Director | 27-Sep-1997 | Current |
| Anand Damani | Director | 24-Feb-2022 | Current |
Financial Performance of Rajendra Chemicals.
Rajendra Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 89.32% increase. The company also saw a substantial improvement in profitability, with a 131.85% increase in profit. The company's net worth moved up by a moderate rise of 6.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajendra Chemicals?
In 2023, Rajendra Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Synthocure Pharma LlpAnand Damani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rajendra Chemicals?
Unlock and access historical data on people associated with Rajendra Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajendra Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajendra Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
